Set Your Sights On TG Therapeutics Inc (NASDAQ: TGTX)’S Upside Potential
TG Therapeutics Inc (TGTX) concluded trading on Thursday at a closing price of $34.55, with 5.84 million shares of worth about $201.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 103.47% during that period and on November 21, 2024 the price saw a […]
TG Therapeutics Inc (NASDAQ: TGTX) Has Another Chance To Impress You
Currently, there are 151.42M common shares owned by the public and among those 138.75M shares have been available to trade. The company’s stock has a 5-day price change of 19.53% and 48.18% over the past three months. TGTX shares are trading 80.97% year to date (YTD), with the 12-month market performance up to 202.45% higher. […]
TG Therapeutics Inc (NASDAQ: TGTX) Hogging The Spotlight Today
Currently, there are 151.42M common shares owned by the public and among those 137.98M shares have been available to trade. The company’s stock has a 5-day price change of 0.04% and 18.37% over the past three months. TGTX shares are trading 42.62% year to date (YTD), with the 12-month market performance up to 134.01% higher. […]
Better Times Ahead For TG Therapeutics Inc (NASDAQ: TGTX)?
TG Therapeutics Inc (TGTX) concluded trading on Thursday at a closing price of $21.83, with 2.33 million shares of worth about $50.96 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.90% during that period and on October 10, 2024 the price saw a […]
Following The Money: Institution’s Growing Stake In TG Therapeutics Inc (NASDAQ: TGTX)
TG Therapeutics Inc (TGTX) concluded trading on Thursady at a closing price of $13.44, with 3.68 million shares of worth about $49.46 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 27.39% during that period and on Thursady the price saw a gain of […]
TG Therapeutics Inc (NASDAQ: TGTX) Is Getting Increasingly Hard To Ignore
Currently, there are 146.39M common shares owned by the public and among those 136.40M shares have been available to trade. Insiders at the company have transacted a total of 10 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
TG Therapeutics Inc (NASDAQ: TGTX): The Best-Of-Breed For Investing?
Currently, there are 146.39M common shares owned by the public and among those 136.40M shares have been available to trade. Insiders at the company have transacted a total of 10 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
TG Therapeutics Inc (NASDAQ: TGTX): Reassessing Prospects
TG Therapeutics Inc (TGTX) concluded trading on Wednesday at a closing price of $16.24, with 5.5 million shares of worth about $89.32 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 54.81% during that period and on Wednesday, January 31 the price saw a […]
Stick With TG Therapeutics Inc (TGTX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in TG Therapeutics Inc (NASDAQ:TGTX). The institutional investor has increased its shareholding in the Healthcare company by 0.07% to 13.06 million shares with purchase of 9159.0 shares. This fresh investment now brings its stake to 8.63% valued currently at $223.14 million. In addition, SSgA […]
Handle With Care: TG Therapeutics Inc (NASDAQ: TGTX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in TG Therapeutics Inc (NASDAQ:TGTX). The institutional investor has increased its shareholding in the Healthcare company by 0.07% to 13.06 million shares with purchase of 9159.0 shares. This fresh investment now brings its stake to 8.63% valued currently at $167.36 million. In addition, SSgA […]
